Oxford Immunotec, now operating as Revvity, is at the forefront of expanding human potential through innovative science and technology. Their portfolio includes the T-SPOT.TB test and other cutting-edge products aimed at revolutionizing T cell measurement.
With a focus on clinical superiority and groundbreaking research, Revvity continues to secure new approvals and accolades, solidifying its position as a leader in the field of latent tuberculosis detection and medical education.
Generated from the website